NCT04661020View on ClinicalTrials.gov

CD19 CAR-T Therapy for Patients With B-cell Non-Hodgkin's Lymphoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 3, 2020

Primary Completion Date

December 20, 2026

Study Completion Date

December 20, 2026

Conditions
Non-hodgkin Lymphoma,B Cell
Interventions
DRUG

CD19 CAR-T cells

Each subject receive CD19 CAR T-cells by intravenous infusion

Trial Locations (1)

310003

RECRUITING

The First Affiliated Hospital，College of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Yake Biotechnology Ltd.

INDUSTRY

lead

Zhejiang University

OTHER